US pharmaceuticals companies risk losing customers unless they do more to stress their commitment to improving people's health, according to a survey of perceptions of the industry to be released today.

With the public playing a growing role in choosing their medicines, four-fifths of consumers say they may switch between brands based on their views of the manufacturer's efforts to develop medicines for unmet medical needs, and make them safe and affordable.